Medical Device Financings: The World Isn't Flat, After All
This article was originally published in Start Up
Anecdotal evidence demonstrates that, at least for certain medical device companies and selected investors, the financing climate is getting better, as up rounds occur with greater frequency.
You may also be interested in...
Three Arch Partners recently raised $400 million in less than a month's time, creating probably the largest pool of venture capital dedicated to medical devices. The fund came together quickly, through existing limited partners. Three Arch told existing investors that it planned to do exactly what has made it successful in the past: focus on medical devices with a smattering of selected services, dedicating a majority of the fund-perhaps 70%--to early stage investments. For investors who have been with Three Arch through its past funds, that works.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.